The impact of crystalloidal and colloidal infusion preparations on coronary vascular integrity, interstitial oedema and cardiac performance in isolated hearts

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Zausig, York A ^a   Chappell, Daniel ^b   Becker, Bernhard F ^b   Potschka, Daniel ^a   Busse, Hendrik ^a   Nixdorf, Kathrin ^b   Bitzinger, Diane ^a   Jacob, Barbara ^b   Jacob, Matthias ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; GELATIN; HETASTARCH; HUMAN ALBUMIN; KREBS HENSELEIT BUFFER; RINGER ACETATE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; CRYSTALLOID; HETASTARCH DERIVATIVE; ISOTONIC SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON; BLOOD FILTRATION; BLOOD VESSEL PERMEABILITY; COLLOID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTALLOID; EXPERIMENTAL GUINEA PIG; GLYCOCALYX; HEART EDEMA; HEART PERFORMANCE; HEART PERFUSION; HEART VENTRICLE PRESSURE; INFUSION; ISOLATED HEART; MALE; NONHUMAN; PH; PRESSURE TRANSDUCER; PRIORITY JOURNAL; VASCULAR CAPACITY; ANIMAL; CARDIOVASCULAR FUNCTION; CORONARY BLOOD VESSEL; DRUG EFFECTS; EDEMA; GUINEA PIG; HEART; INTRAVENOUS DRUG ADMINISTRATION; ORGAN CULTURE TECHNIQUE; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION;

ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CORONARY VESSELS; EDEMA; GUINEA PIGS; HEART; HYDROXYETHYL STARCH DERIVATIVES; INFUSIONS, INTRAVENOUS; ISOTONIC SOLUTIONS; MALE; ORGAN CULTURE TECHNIQUES; RANDOM ALLOCATION;

EID: 84883668758     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12898     Document Type: Article

References (25)

1. Starling E. On the absorption of fluid from the connective tissue spaces. J Physiol (Lond) 1896, 19:312-326. 1512609, 16992325.
2. Adamson RH, Lenz JF, Zhang X, Adamson GN, Weinbaum S, Curry FE. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol 2004, 557:889-907. 10.1113/jphysiol.2003.058255, 1665140, 15073281.
3. Rehm M, Zahler S, Lotsch M, Welsch U, Conzen P, Jacob M, Becker BF. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004, 100:1211-1223. 10.1097/00000542-200405000-00025, 15114220.
4. Jacob M, Bruegger D, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF. The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007, 73:575-586. 10.1016/j.cardiores.2006.11.021, 17196565.
5. Becker BF, Chappell D, Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol 2010, 105:687-701.
6. Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010, 87:300-310. 10.1093/cvr/cvq137, 20462866.
7. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007, 9:121-167. 10.1146/annurev.bioeng.9.060906.151959, 17373886.
8. Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006, 104:1223-1231. 10.1097/00000542-200606000-00018, 16732094.
9. Chappell D, Jacob M, Hofmann-Kiefer K, Rehm M, Welsch U, Conzen P, Becker BF. Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc Res 2009, 83:388-396. 10.1093/cvr/cvp097, 19307232.
10. Chappell D, Doerfler N, Jacob M, Rehm M, Welsch U, Conzen P, Becker BF. Glycocalyx protection reduces leukocyte adhesion following ischemia/reperfusion. Shock 2010, 34:133-139. 10.1097/SHK.0b013e3181cdc363, 20634656.
11. Jacob M, Paul O, Mehringer L, Chappell D, Rehm M, Welsch U, Kaczmarek I, Conzen P, Becker BF. Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation 2009, 87:956-965. 10.1097/TP.0b013e31819c83b5, 19352113.
12. Zahler S, Kupatt C, Seligmann C, Kowalski C, Becker BF, Gerlach E. Retention of leucocytes in reperfused, isolated hearts does not cause haemodynamically relevant permanent capillary plugging. Pflugers Arch 1997, 433:713-720. 10.1007/s004240050336, 9049161.
13. Chappell D, Jacob M, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF. Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx. Biol Chem 2008, 389:79-82.
14. Zausig YA, Zink W, Keil M, Sinner B, Barwing J, Wiese CH, Graf BM. Lipid emulsion improves recovery from bupivacaine-induced cardiac arrest, but not from ropivacaine- or mepivacaine-induced cardiac arrest. Anesth Analg 2009, 109:1323-1326. 10.1213/ane.0b013e3181af7fb3, 19762764.
15. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191. 10.3758/BF03193146, 17695343.
16. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012, 255:821-829. 10.1097/SLA.0b013e31825074f5, 22470070.
17. Orchard CH, Kentish JC. Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol 1990, 258:C967-C981.
18. Fabiato A, Fabiato F. Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles. J Physiol 1978, 276:233-255. 1282422, 25957.
19. Zhou HZ, Malhotra D, Shapiro JI. Contractile dysfunction during metabolic acidosis: role of impaired energy metabolism. Am J Physiol 1991, 261:H1481-H1486.
20. Coles JA, Sigg DC, Iaizzo PA. The potential benefits of 1.5% hetastarch as a cardioplegia additive. Biochem Pharmacol 2005, 69:1553-1558. 10.1016/j.bcp.2005.03.010, 15896334.
21. Dagtekin O, Klisa MA, Gerbershagen HJ, Marcus H, Krep H, Teschendorf P, Fischer JH. Effects of hydroxyethyl starch, gelatin and dextran on endothelium-derived relaxation in porcine coronary arteries. Pharmacology 2010, 86:267-272. 10.1159/000320955, 20980779.
22. Sutherland FJ, Hearse DJ. The isolated blood and perfusion fluid perfused heart. Pharmacol Res 2000, 41:613-627. 10.1006/phrs.1999.0653, 10816330.
23. Koller A, Sun D, Kaley G. Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 1993, 72:1276-1284. 10.1161/01.RES.72.6.1276, 8495555.
24. Gregg DE. Relationship between coronary flow and metabolic changes. Cardiology 1971, 56:291-301. 10.1159/000169373, 4949061.
25. Podesser BK, Hallstrom S, Schima H, Huber L, Weisser J, Kroner A, Furst W, Wolner E. The erythrocyte-perfused "working heart" model: hemodynamic and metabolic performance in comparison to crystalloid perfused hearts. J Pharmacol Toxicol Methods 1999, 41:9-15. 10.1016/S1056-8719(99)00018-0, 10507753.